Free Goods Programme
We aim to help solve the toughest imbalances in access to medicine and to positively impact people’s lives around the world.
At Cycle Pharma, we are committed to developing safe and effective therapies and making them available to as many patients as possible.
We’re committed to helping rare disease patients irrespective of their ability to pay for treatment. This is written into the constitutional documents of our company, and we’ve been running a Free Goods Programme since 2018.
A Free Goods Programme (also known as a Special Access Scheme or Compassionate Use Programme) is a compliant way for medicines that are not approved in their country of intended use to be made available for patients who either have no alternative treatment option or have exhausted all other treatment options available in their country of residence.
HT-1 and AKU are both ultra-rare diseases, and they are both diseases that patients have for life. They can be treated with nitisinone, in combination with dietary restriction of tyrosine and phenylalanine.
We aim to provide nitisinone to 100 patients on the Free Goods Programme and are committed to providing it to these patients for free, for the duration of their life.
Our Free Goods Programme is currently available to patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) who live in countries where it is unlikely that they will have the means to pay for rare disease medication, including:
- Argentina
- Bangladesh
- Brazil
- Chile
- Colombia
- Dominican Republic
- India
- Jordan
- Mexico
- Nigeria
- Pakistan
- Peru
- Sudan
- Tunisia
- Turkey
How to access
If you are a Healthcare Provider (HCP) who believes that access to nitisinone would be suitable for your patient, you should contact Cycle Pharma via medinfo@cyclepharma.com or visit www.inceptua.com to make the request on behalf of your patient. These requests should not include information that identifies the patient.
Supply to the patient under the programme must not break any local laws or regulations. Cycle Pharma will add patients to the programme on a first come first served basis.
Making it possible
We have partnered with Inceptua to provide our Free Goods Programme.
Find out more at www.inceptua.com
For Cycle Pharmaceuticals Medical Information
Telephone
+1 800 841 0898
Email
medinfo@cyclepharma.com